THERAPY DOSSIER · th-a77f2008739d

Eriobotrya japonica seed extract with deep sea water

Nutraceutical

Evidence & regulatory context

Mechanism: Not recorded
Target: Not recorded
Injury models: Chemical/toxin
Reported indication: Not recorded
First approval: Not recorded
Development stage: Not recorded
ChEMBL record: Not recorded
ChEMBL max phase: Not recorded
Synonyms: Not recorded
Note: Not recorded

Clinical trials 1

0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.

NCT02401113 ↗PHASE2/PHASE3completed

Effect of Ursolic Acid of Loquat Extract on Function of Muscle in Human

Sarcopenia

Enrolment: 54 · Results not recorded

Preclinical evidence 1

1 studies reported at therapy level; 1 evidence entries itemised.

PMID 20640522 ↗2010Reported benefit

Eriobotrya japonica seed extract and deep sea water protect against indomethacin-induced gastric mucosal injury in rats.

RatChemical/toxinWistar/STMaleOralIndomethacin 30 mg/kg; extract at human-equivalent concentr…Around indomethacin exposure

Model: Indomethacin-induced acute gastric mucosal injury

Eriobotrya japonica seed extract, combined with deep sea water, reduced gastric injury area and lipid peroxide and raised antioxidant enzymes.

Extraction: extract · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.

Loading the evidence…